Raul G Nogueira1, Osama O Zaidat2, Alicia C Castonguay2, Diogo C Haussen1, Coleman O Martin3, William E Holloway3, Nils Mueller-Kronast4, Joey English5, Italo Linfante6, Guilherme Dabus6, Tim W Malisch7, Franklin A Marden7, Hormozd Bozorgchami8, Andrew Xavier9, Ansaar T Rai10, Michael T Froehler11, Aamir Badruddin12, Thanh N Nguyen13, M Asif Taqi14, Michael G Abraham15, Vallabh Janardhan16, Albert J Yoo16, Hashem Shaltoni17, Alex Abou-Chebl18, Peng R Chen19, Gavin W Britz20, Roberta Novakovic21, Ashish Nanda22, Ritesh Kaushal23, Mohammad A Issa2, Michael R Frankel1, Rishi Gupta24. 1. Department of Neurology, Emory University School of Medicine, Atlanta, Ga., USA. 2. Department of Neurology, Medical College of Wisconsin, Milwaukee, Wis., USA. 3. St. Luke's Neuroscience Institute, Kansas City, Mo., USA. 4. Department of Neurology, Delray Medical Center, Delray Beach, Fla., USA. 5. California Pacific Medical Center, San Francisco, Calif., USA. 6. Division of Interventional Neuroradiology, Baptist Cardiac and Vascular Institute, Miami, Fla., USA. 7. Alexian Brothers Medical Center, Elk Grove Village, Ill., USA. 8. Oregon Health and Sciences, Portland, Oreg., USA. 9. Department of Neurology, Wayne State University School of Medicine, Detroit, Mich., USA. 10. Department of Radiology, West Virginia University Hospital, Morgantown, W.Va., USA. 11. Department of Neurology, Neurosurgery, and Radiology, Vanderbilt University Medical Center, Nashville, Tenn., USA. 12. Department of Neurosurgery, Presence Saint Joseph Medical Center, Joliet, Ill., USA. 13. Department of Neurology, Boston University School of Medicine, Boston, Mass., USA. 14. Desert Regional Medical Center, Palm Springs, Calif., USA. 15. University of Kansas Medical Center, Kansas City, Kans., USA. 16. Texas Stroke Institute, Dallas Fort-Worth Metroplex, Tex., USA. 17. Baylor College of Medicine, Houston, Tex., USA. 18. Department of Neurology, University of Louisville Medical School, Louisville, Ky., USA. 19. Department of Neurosurgery, University of Texas, Houston, Tex., USA. 20. Department of Neurosurgery, Methodist Neurological Institute, Houston, Tex., USA. 21. Department of Radiology and Neurology, UT Southwestern Medical Center, Dallas, Tex., USA. 22. University of Missouri, Columbia, Mo., USA. 23. Saint Louis University, St. Louis, Mo., USA. 24. Department of Neurosurgery, Wellstar Medical Group, Marietta., USA.
Abstract
BACKGROUND: The Interventional Management of Stroke III (IMS-III) trial demonstrated no benefit for intravenous recombinant tissue plasminogen activator (IV rt-PA) followed by endovascular therapy versus IV rt-PA alone. However, IMS-III mostly included earlier generation devices. The recent thrombectomy trials have incorporated the stent-retriever technology, but their generalizability remains unknown. METHODS: The North American Solitaire Acute Stroke (NASA) registry recruited patients treated with the Solitaire FR™ device between March 2012 and February 2013. The NASA-IMS-III-Like Group (NILG baseline NIHSS score ≥10 who received IV rt-PA) was compared to the IV rt-PA and IV + intra-arterial (IA)-IMS-III groups and the MR CLEAN, ESCAPE, SWIFT Prime, and REVASCAT trial controls to assess the stent-retriever treatment in the 'real-world' setting. The NILG was also compared to non-IV rt-PA NASA patients to evaluate the impact of IV rt-PA on thrombectomy. RESULTS: A total of 136 of the 354 NASA patients fulfilled criteria for the NILG. Baseline characteristics were well balanced across groups. Time from onset to puncture was higher in NILG than IV+IA-IMS-III patients (274 ± 112 vs. 208 ± 47 min, p < 0.0001). Occlusions involving the intracranial ICA, MCA-M1, or basilar arteries were more common in NILG than IV+IA-IMS-III patients (91.2 vs. 47.2%, p < 0.00001). Modified thrombolysis in cerebral infarction ≥2b reperfusion was higher in NILG than IV+IA-IMS-III patients (74.3 vs. 39.6%, p < 0.00001). A 90-day modified Rankin Scale score ≤2 was more frequent in the NILG than IV+IA-IMS-III patients (51.9 vs. 40.8%, p = 0.03) and MR CLEAN (51.9 vs. 19.1%, p < 0.00001), ESCAPE (51.9 vs. 29.3%, p = 0.0002), SWIFT Prime (51.9 vs. 35.5%, p = 0.02), and REVASCAT (51.9 vs. 28.2%, p = 0.0003) controls. Symptomatic intracranial hemorrhage definitions varied across the different studies with rates ranging from 2.7% (ESCAPE) to 11.9% (NILG). The NILG 90-day mortality (24.4%) was higher than in SWIFT Prime but comparable to all other groups. IV rt-PA was an independent predictor of good outcome in NASA (OR = 2.3, 95% CI 1.2-4.7). CONCLUSION: Our results support the 'real-world' applicability of the recent thrombectomy trials.
BACKGROUND: The Interventional Management of Stroke III (IMS-III) trial demonstrated no benefit for intravenous recombinant tissue plasminogen activator (IV rt-PA) followed by endovascular therapy versus IV rt-PA alone. However, IMS-III mostly included earlier generation devices. The recent thrombectomy trials have incorporated the stent-retriever technology, but their generalizability remains unknown. METHODS: The North American Solitaire Acute Stroke (NASA) registry recruited patients treated with the Solitaire FR™ device between March 2012 and February 2013. The NASA-IMS-III-Like Group (NILG baseline NIHSS score ≥10 who received IV rt-PA) was compared to the IV rt-PA and IV + intra-arterial (IA)-IMS-III groups and the MR CLEAN, ESCAPE, SWIFT Prime, and REVASCAT trial controls to assess the stent-retriever treatment in the 'real-world' setting. The NILG was also compared to non-IV rt-PA NASA patients to evaluate the impact of IV rt-PA on thrombectomy. RESULTS: A total of 136 of the 354 NASA patients fulfilled criteria for the NILG. Baseline characteristics were well balanced across groups. Time from onset to puncture was higher in NILG than IV+IA-IMS-III patients (274 ± 112 vs. 208 ± 47 min, p < 0.0001). Occlusions involving the intracranial ICA, MCA-M1, or basilar arteries were more common in NILG than IV+IA-IMS-III patients (91.2 vs. 47.2%, p < 0.00001). Modified thrombolysis in cerebral infarction ≥2b reperfusion was higher in NILG than IV+IA-IMS-III patients (74.3 vs. 39.6%, p < 0.00001). A 90-day modified Rankin Scale score ≤2 was more frequent in the NILG than IV+IA-IMS-III patients (51.9 vs. 40.8%, p = 0.03) and MR CLEAN (51.9 vs. 19.1%, p < 0.00001), ESCAPE (51.9 vs. 29.3%, p = 0.0002), SWIFT Prime (51.9 vs. 35.5%, p = 0.02), and REVASCAT (51.9 vs. 28.2%, p = 0.0003) controls. Symptomatic intracranial hemorrhage definitions varied across the different studies with rates ranging from 2.7% (ESCAPE) to 11.9% (NILG). The NILG 90-day mortality (24.4%) was higher than in SWIFT Prime but comparable to all other groups. IV rt-PA was an independent predictor of good outcome in NASA (OR = 2.3, 95% CI 1.2-4.7). CONCLUSION: Our results support the 'real-world' applicability of the recent thrombectomy trials.
Entities:
Keywords:
Interventional Management of Stroke III trial; Intravenous thrombolysis; Large vessel occlusion; Rescue thrombectomy
Authors: Raul G Nogueira; Helmi L Lutsep; Rishi Gupta; Tudor G Jovin; Gregory W Albers; Gary A Walker; David S Liebeskind; Wade S Smith Journal: Lancet Date: 2012-08-26 Impact factor: 79.321
Authors: Jeffrey L Saver; Reza Jahan; Elad I Levy; Tudor G Jovin; Blaise Baxter; Raul G Nogueira; Wayne Clark; Ronald Budzik; Osama O Zaidat Journal: Lancet Date: 2012-08-26 Impact factor: 79.321
Authors: Jeffrey L Saver; Mayank Goyal; Alain Bonafe; Hans-Christoph Diener; Elad I Levy; Vitor M Pereira; Gregory W Albers; Christophe Cognard; David J Cohen; Werner Hacke; Olav Jansen; Tudor G Jovin; Heinrich P Mattle; Raul G Nogueira; Adnan H Siddiqui; Dileep R Yavagal; Blaise W Baxter; Thomas G Devlin; Demetrius K Lopes; Vivek K Reddy; Richard du Mesnil de Rochemont; Oliver C Singer; Reza Jahan Journal: N Engl J Med Date: 2015-04-17 Impact factor: 91.245
Authors: Diogo C Haussen; Raul G Nogueira; Mohamed Samy Elhammady; Dileep R Yavagal; Mohammad Ali Aziz-Sultan; Jeremiah N Johnson; Brandon G Gaynor; Shyian Jen; Seena Dehkharghani; Eric C Peterson Journal: J Neurointerv Surg Date: 2014-12-24 Impact factor: 5.836
Authors: Bruce C V Campbell; Peter J Mitchell; Timothy J Kleinig; Helen M Dewey; Leonid Churilov; Nawaf Yassi; Bernard Yan; Richard J Dowling; Mark W Parsons; Thomas J Oxley; Teddy Y Wu; Mark Brooks; Marion A Simpson; Ferdinand Miteff; Christopher R Levi; Martin Krause; Timothy J Harrington; Kenneth C Faulder; Brendan S Steinfort; Miriam Priglinger; Timothy Ang; Rebecca Scroop; P Alan Barber; Ben McGuinness; Tissa Wijeratne; Thanh G Phan; Winston Chong; Ronil V Chandra; Christopher F Bladin; Monica Badve; Henry Rice; Laetitia de Villiers; Henry Ma; Patricia M Desmond; Geoffrey A Donnan; Stephen M Davis Journal: N Engl J Med Date: 2015-02-11 Impact factor: 91.245
Authors: Olvert A Berkhemer; Puck S S Fransen; Debbie Beumer; Lucie A van den Berg; Hester F Lingsma; Albert J Yoo; Wouter J Schonewille; Jan Albert Vos; Paul J Nederkoorn; Marieke J H Wermer; Marianne A A van Walderveen; Julie Staals; Jeannette Hofmeijer; Jacques A van Oostayen; Geert J Lycklama à Nijeholt; Jelis Boiten; Patrick A Brouwer; Bart J Emmer; Sebastiaan F de Bruijn; Lukas C van Dijk; L Jaap Kappelle; Rob H Lo; Ewoud J van Dijk; Joost de Vries; Paul L M de Kort; Willem Jan J van Rooij; Jan S P van den Berg; Boudewijn A A M van Hasselt; Leo A M Aerden; René J Dallinga; Marieke C Visser; Joseph C J Bot; Patrick C Vroomen; Omid Eshghi; Tobien H C M L Schreuder; Roel J J Heijboer; Koos Keizer; Alexander V Tielbeek; Heleen M den Hertog; Dick G Gerrits; Renske M van den Berg-Vos; Giorgos B Karas; Ewout W Steyerberg; H Zwenneke Flach; Henk A Marquering; Marieke E S Sprengers; Sjoerd F M Jenniskens; Ludo F M Beenen; René van den Berg; Peter J Koudstaal; Wim H van Zwam; Yvo B W E M Roos; Aad van der Lugt; Robert J van Oostenbrugge; Charles B L M Majoie; Diederik W J Dippel Journal: N Engl J Med Date: 2014-12-17 Impact factor: 91.245
Authors: Mayank Goyal; Andrew M Demchuk; Bijoy K Menon; Muneer Eesa; Jeremy L Rempel; John Thornton; Daniel Roy; Tudor G Jovin; Robert A Willinsky; Biggya L Sapkota; Dar Dowlatshahi; Donald F Frei; Noreen R Kamal; Walter J Montanera; Alexandre Y Poppe; Karla J Ryckborst; Frank L Silver; Ashfaq Shuaib; Donatella Tampieri; David Williams; Oh Young Bang; Blaise W Baxter; Paul A Burns; Hana Choe; Ji-Hoe Heo; Christine A Holmstedt; Brian Jankowitz; Michael Kelly; Guillermo Linares; Jennifer L Mandzia; Jai Shankar; Sung-Il Sohn; Richard H Swartz; Philip A Barber; Shelagh B Coutts; Eric E Smith; William F Morrish; Alain Weill; Suresh Subramaniam; Alim P Mitha; John H Wong; Mark W Lowerison; Tolulope T Sajobi; Michael D Hill Journal: N Engl J Med Date: 2015-02-11 Impact factor: 91.245
Authors: Joseph P Broderick; Yuko Y Palesch; Andrew M Demchuk; Sharon D Yeatts; Pooja Khatri; Michael D Hill; Edward C Jauch; Tudor G Jovin; Bernard Yan; Frank L Silver; Rüdiger von Kummer; Carlos A Molina; Bart M Demaerschalk; Ronald Budzik; Wayne M Clark; Osama O Zaidat; Tim W Malisch; Mayank Goyal; Wouter J Schonewille; Mikael Mazighi; Stefan T Engelter; Craig Anderson; Judith Spilker; Janice Carrozzella; Karla J Ryckborst; L Scott Janis; Renée H Martin; Lydia D Foster; Thomas A Tomsick Journal: N Engl J Med Date: 2013-02-07 Impact factor: 91.245
Authors: Thanh N Nguyen; Timothy Malisch; Alicia C Castonguay; Rishi Gupta; Chung-Huan J Sun; Coleman O Martin; William E Holloway; Nils Mueller-Kronast; Joey D English; Italo Linfante; Guilherme Dabus; Franklin A Marden; Hormozd Bozorgchami; Andrew Xavier; Ansaar T Rai; Michael T Froehler; Aamir Badruddin; Muhammad Taqi; Michael G Abraham; Vallabh Janardhan; Hashem Shaltoni; Roberta Novakovic; Albert J Yoo; Alex Abou-Chebl; Peng R Chen; Gavin W Britz; Ritesh Kaushal; Ashish Nanda; Mohammad A Issa; Hesham Masoud; Raul G Nogueira; Alexander M Norbash; Osama O Zaidat Journal: Stroke Date: 2013-12-03 Impact factor: 7.914
Authors: Alex Abou-Chebl; Ossama O Zaidat; Alicia C Castonguay; Rishi Gupta; Chung-Huan J Sun; Coleman O Martin; William E Holloway; Nils Mueller-Kronast; Joey D English; Italo Linfante; Guilherme Dabus; Timothy W Malisch; Franklin A Marden; Hormozd Bozorgchami; Andrew Xavier; Ansaar T Rai; Micahel T Froehler; Aamir Badruddin; Thanh N Nguyen; Muhammad Taqi; Michael G Abraham; Vallabh Janardhan; Hashem Shaltoni; Roberta Novakovic; Albert J Yoo; Peng R Chen; Gavin W Britz; Ritesh Kaushal; Ashish Nanda; Mohammad A Issa; Raul G Nogueira Journal: Stroke Date: 2014-03-25 Impact factor: 7.914
Authors: D Sacks; B Baxter; B C V Campbell; J S Carpenter; C Cognard; D Dippel; M Eesa; U Fischer; K Hausegger; J A Hirsch; M S Hussain; O Jansen; M V Jayaraman; A A Khalessi; B W Kluck; S Lavine; P M Meyers; S Ramee; D A Rüfenacht; C M Schirmer; D Vorwerk Journal: AJNR Am J Neuroradiol Date: 2018-05-17 Impact factor: 3.825
Authors: Osama O Zaidat; Alicia C Castonguay; Raul G Nogueira; Diogo C Haussen; Joey D English; Sudhakar R Satti; Jennifer Chen; Hamed Farid; Candace Borders; Erol Veznedaroglu; Mandy J Binning; Ajit Puri; Nirav A Vora; Ron F Budzik; Guilherme Dabus; Italo Linfante; Vallabh Janardhan; Amer Alshekhlee; Michael G Abraham; Randall Edgell; Muhammad Asif Taqi; Ramy El Khoury; Maxim Mokin; Aniel Q Majjhoo; Mouhammed R Kabbani; Michael T Froehler; Ira Finch; Sameer A Ansari; Roberta Novakovic; Thanh N Nguyen Journal: J Neurointerv Surg Date: 2017-09-29 Impact factor: 5.836